Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a multi-year strategic collaboration with Novartis Pharmaceuticals Corporation (“Novartis”) to deploy a series of artificial intelligence (AI)-powered software solutions that will detect hidden cardiovascular conditions
News | Artificial Intelligence
Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

July 14, 2022 — Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a ...

Home July 14, 2022
Home
News | Cardiac Imaging
AvoMD Partners with the SCCT to bring guidelines to the point-of-care

July 14, 2022 – AvoMD, a next-generation application-based clinical decision support platform, is working with the ...

Home July 14, 2022
Home
The authors analyzed data about 8,224 children who received cardiac transplants from January 1994 through September 2019. The data came from the Scientific Registry of Transplant Recipients (SRTR), a national database of all organ transplants in the United States. The researchers adjusted their analyses for factors including age, sex, cognitive difficulties, insurance status, transplant year and the reason for heart transplant.
News | Pediatric Cardiology
Study Finds Risk Disparity for Black Children Who Have Stroke After Heart Transplant

July 13, 2022 — Black children who underwent heart transplant surgery for the first time were more than three times as ...

Home July 13, 2022
Home
Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and MRI techniques could be used to detect the condition and predict future sudden cardiac death (SCD),
News | Sudden Cardiac Arrest
Johns Hopkins Medicine Study: Abnormal Heart Metabolism May Predict Future Sudden Cardiac Death 

July 13, 2022 — Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening ...

Home July 13, 2022
Home
the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the AccuCinch Ventricular Restoration System
News | Heart Failure
Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System

July 13, 2022 — Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today ...

Home July 13, 2022
Home
July/August 2022 issue of Diagnostic and Interventional Cardiology
Feature | Cardiovascular Business
DAIC's July/August Digital Edition is Now Available

View the July/August digital edition of Diagnostic and Interventional Cardiology (DAIC), including links to videos ...

Home July 13, 2022
Home
News | SCCT
SCCT Names Finalists for Best Abstract and Canon Young Investigator Awards

July 13, 2022 — Ahead of its 2022 Annual Scientific Meeting, July 15 – 17 in Las Vegas, the Society of Cardiovascular ...

Home July 13, 2022
Home
News | SCCT | SCCT
Developments in AIU, Plaque Assessment to be Showcased at SCCT2022

July 13, 2022 — The Society of Cardiovascular Computed Tomography (SCCT) has released an update on the device ...

Home July 13, 2022
Home
The BIO REACT study was designed to better understand when and where a stent is needed following drug-coated balloon for the treatment of femoropopliteal artery lesions in patients with peripheral artery disease (PAD)
News | Drug-Eluting Balloons
New Data at LINC 2022 Confirm Passeo-18 Lux Drug-Coated Balloon is a Safe and Effective Treatment in Challenging Patient Groups

July 12, 2022 — Biotronik announced the presentation of two studies on the performance of its drug-coated balloon ...

Home July 12, 2022
Home
A Multi-Disciplinary Group of MedTech Stakeholders Will Convene Just Before the Main Sessions of TCT 2022 to Provide Real-World Insight into Health Technology Advancements, Challenges, and Opportunities
News | TCT
CRF and Fogarty Innovation Launch the “TCT MedTech Innovation Forum”

July 12, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that they are ...

Home July 12, 2022
Home
Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according to a review paper published today in Cardiovascular Research
News | Heart Failure
Scientists Warn of Links Between Soil Pollution and Heart Disease

July 12, 2022 — Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according ...

Home July 12, 2022
Home
medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform
News | Cardiovascular Business
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center

July 11, 2022 — BioSig Technologies, Inc., a medical technology company advancing electrophysiology workflow by ...

Home July 12, 2022
Home
An ablation was performed to correct Rod’s irregular heartbeat and a defibrillator implanted that can restart his heart within ten seconds in case of cardiac arrest
News | Sudden Cardiac Arrest
Diagnosis and Treatment at Memorial Cardiac and Vascular Institute Eliminates Patient's Risk of 'Sudden Cardiac Death'

July 11, 2022 — Rod was diagnosed with cancer, but it wasn’t his most urgent medical issue. A few months after that ...

Home July 12, 2022
Home
Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold rise in exhaled carbon monoxide and impaired blood vessel function compared to non-mask periods
News | Cardiovascular Clinical Studies
Mask Wearing Amplifies Harms of Smoking

July 11, 2022 — Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold ...

Home July 12, 2022
Home
News | PET-CT
Aetna Reverses Cardiac PET/CT Non-coverage Policy

July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...

Home July 11, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now